May 2007
Volume 48, Issue 13
ARVO Annual Meeting Abstract  |   May 2007
Effects of Phosphatidylcholine on Xanthelasma
Author Affiliations & Notes
  • J.-Y. Kim
    Oculoplasty, Lee-Yeon, Gwang-Ju,, Republic of Korea
  • S.-J. Kang
    Oculoplasty, Lee-Yeon, Gwang-Ju,, Republic of Korea
  • D.-J. Oh
    Aesthetic, Dong Jin Clinic, Dam Yang, Jeon La Nam Do, Republic of Korea
  • Footnotes
    Commercial Relationships J. Kim, None; S. Kang, None; D. Oh, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 5228. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.-Y. Kim, S.-J. Kang, D.-J. Oh; Effects of Phosphatidylcholine on Xanthelasma. Invest. Ophthalmol. Vis. Sci. 2007;48(13):5228.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose:: To identify the effects of phosphatidylcholine on xanthlasma occurring on the eyelid.

Methods:: From February 2004 to September 2005, we had injected phosphatidylcholine in xanthelasma on the both upper eyelids of eight patients ( 3 males, aged 51-67 and 5 females, aged 45-63) who had asymmetrical and large xanthelasma, which is usually found hard to be removed by surgery or other treatments. It was injected weekly at the lesion using 1cc syringe with 30 gauge needle for 8 to 10 times.

Results:: None of the eight patients had side-effects from injection and also, there was no complication, such as asymmetry or scar on the eyelids, that the surgery might cause. Also, xanthelasma has not reoccurred for more than one year as observed.

Conclusions:: Phosphatidylcholine removed xanthelasma without side-effects and it is recommended that it can be used as an effective alternative to surgery or the other specific treatment.

Keywords: eyelid • tumors • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.